Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Aimei Health Technology Co., Ltd Unit (AFJKU)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/11/2025: AFJKU (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -0.44% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/11/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 10.51 - 12.90 | Updated Date 06/5/2025 |
52 Weeks Range 10.51 - 12.90 | Updated Date 06/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -0.92% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 69617552 | Price to Sales(TTM) - |
Enterprise Value 69617552 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 3988921 |
Shares Outstanding - | Shares Floating 3988921 | ||
Percent Insiders 5.53 | Percent Institutions 0.04 |
Upturn AI SWOT
Aimei Health Technology Co., Ltd Unit
Company Overview
History and Background
Aimei Health Technology Co., Ltd Unit is not a publicly traded US company. Therefore, detailed information about its founding year, milestones, and evolution is unavailable in standard US stock market data sources.
Core Business Areas
- Segment Name 1: Information unavailable due to the company not being publicly traded on the US stock market.
Leadership and Structure
Information unavailable due to the company not being publicly traded on the US stock market.
Top Products and Market Share
Key Offerings
- Product Name 1: Information unavailable due to the company not being publicly traded on the US stock market.
Market Dynamics
Industry Overview
Information unavailable due to the company not being publicly traded on the US stock market.
Positioning
Information unavailable due to the company not being publicly traded on the US stock market.
Total Addressable Market (TAM)
Information unavailable due to the company not being publicly traded on the US stock market.
Upturn SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
Competitors and Market Share
Key Competitors
Competitive Landscape
Information unavailable due to the company not being publicly traded on the US stock market.
Growth Trajectory and Initiatives
Historical Growth: Information unavailable due to the company not being publicly traded on the US stock market.
Future Projections: Information unavailable due to the company not being publicly traded on the US stock market.
Recent Initiatives: Information unavailable due to the company not being publicly traded on the US stock market.
Summary
Aimei Health Technology Co., Ltd Unit is not a publicly traded US company, so comprehensive financial data and competitive analysis are unavailable. Consequently, evaluating its strength, weaknesses, and market position is not feasible using standard US stock market resources. Further information from private sources would be required for a thorough assessment. The company may not have competitors or comparable structures that are publicly traded. Further research is needed to analyze its performance and potential.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Publicly available information about US stock market companies.
Disclaimers:
The information provided is based on the understanding that Aimei Health Technology Co., Ltd Unit is not a publicly traded US company. Analysis is limited by the lack of available data. This analysis is not a substitute for professional financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aimei Health Technology Co., Ltd Unit
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2023-12-04 | CEO, Secretary & Director Mr. Junheng Xie | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | Website |
Full time employees - | Website | ||
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.